Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07374848 · ClinicalTrials.gov registry record · Phase 1
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
A Phase 1 study of Solid Tumors and Sarcomas, sponsored by Zai Lab (Shanghai) Co..
- Recruiting
- Registry status
- Phase 1
- Development phase
- 180
- Enrollment target
- 2
- Study locations
NCT07374848 is a Phase 1 study of Solid Tumors and Sarcomas that is actively recruiting participants, run by Zai Lab (Shanghai) Co.. The registered enrollment target is 180 participants, below the 283-participant average among 125 other Solid Tumors trials with a reported enrollment target (36% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07374848, a Phase 1 study of Solid Tumors and Sarcomas, is actively recruiting participants, sponsored by Zai Lab (Shanghai) Co..
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 180 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and tolerability of investigational study drug ZL-6201 for treating sarcoma and solid tumors cancer.
Conditions Studied
Interventions
- DRUG ZL-6201
Study Locations (2)
Florida
- Zai Lab Site 02026 - Sarasota
Virginia
- Zai Lab Site 02006 - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-03 |
| Est. Completion | 2029-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07374848
The ClinicalTrials.gov registry entry for NCT07374848 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 283-participant average among 125 other Solid Tumors trials with a reported enrollment target (36% lower). The listed sponsor is Zai Lab (Shanghai) Co., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which ZL-6201 is the first listed.
NCT07374848 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Virginia.
Frequently Asked Questions
What is clinical trial NCT07374848 about?
NCT07374848 is a clinical study titled "Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors". The purpose of this study is to evaluate the safety and tolerability of investigational study drug ZL-6201 for treating sarcoma and solid tumors cancer.
What is the current status of trial NCT07374848?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 180 participants. The study started on 2026-03. Estimated completion is 2029-09.
What conditions does trial NCT07374848 study?
This clinical trial studies the following conditions: Solid Tumors, Sarcomas.
What interventions are being tested in trial NCT07374848?
The interventions under investigation include: ZL-6201 (DRUG).
Who is sponsoring clinical trial NCT07374848?
This trial is sponsored by Zai Lab (Shanghai) Co., which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07374848 being conducted?
This trial has 2 study locations across Florida, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RECRUITING · Phase 1
-
Study of AUBE00 in Patients With Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.